晚期髓性甲状腺癌因COVID-19患者持续升高的公素水平而被发现

Ines Bucci1,2, Giulia Di Dalmazi2, Cesidio Giuliani1

  • 1Department of Medicine and Aging Sciences, Center for Advanced Studies and Technology (CAST), G.d'Annunzio University Chieti-Pescara, Chieti, Italy.

概括

在COVID-19患者中,高甲激素水平表明甲状腺髓性癌 (MTC). 先进的MTC可能进展缓慢,卡博桑提尼布有效地管理了患者.